Neuron-type specific cannabinoid-mediated G protein signalling in mouse hippocampus

Area of Science:

• Neuroscience
• Pharmacology
• Molecular Biology

Background:

• Type 1 cannabinoid receptor (CB1) is expressed across diverse neuronal populations in the mammalian brain.
• CB1 receptors on GABAergic and glutamatergic neurons exhibit distinct functions and pharmacological properties.
• This suggests neuron-type specific signaling pathways activated by distinct CB1 subpopulations.

Purpose of the Study:

• To investigate CB1 expression, binding, and signaling in the hippocampus of conditional mutant mice with CB1 deletion in specific neuronal types.
• To compare CB1 signaling efficiency between glutamatergic and GABAergic neurons in vivo.

Main Methods:

• Utilized conditional mutant mice lacking CB1 in GABAergic (GABA-CB1-KO) or cortical glutamatergic neurons (Glu-CB1-KO).
• Analyzed CB1 mRNA levels, immunoreactivity, and [³H]CP55,940 binding.
• Assessed HU210-stimulated [(35)S]GTPγS binding to evaluate G protein coupling efficiency.

Main Results:

• GABA-CB1-KO mice showed a significant reduction in CB1 expression and binding, indicating higher CB1 density on hippocampal GABAergic interneurons.
• Glu-CB1-KO mice exhibited a minor decrease in CB1 parameters.
• Despite lower expression, 'glutamatergic' CB1 demonstrated significantly higher G protein coupling efficiency compared to 'GABAergic' CB1.

Conclusions:

• CB1 receptors exhibit differential G protein coupling depending on the neuronal subtype.
• The higher signaling efficiency of CB1 on glutamatergic neurons, despite lower density, presents a novel target.
• This finding opens avenues for designing cannabinoid ligands that selectively modulate specific physiological effects for therapeutic benefit.